Abstract
We identified UL16 binding protein 2 (ULBP2) as a protein overexpressed in pancreatic cancer tissues, and found that ULBP2 levels were significantly higher in pancreatic cancer patients than those in healthy controls. This invention provides a method to detect pancreatic cancer using ULBP2 as a serological marker. We also found that combination of ULBP2 and CA19-9 promotes the efficacy of pancreatic cancer detection. We measured the blood ULBP2 levels in patients with other cancer types, including colorectal carcinoma, nasopharyngeal carcinoma and gastric cancer. We found that blood ULBP2 levels were higher in patients with pancreatic cancer than other cancer types.
| Translated title of the contribution | A SEROLOGICAL MAKER FOR DETECTING PANCREATIC CANCER AND A METHOD FOR USING THE SEROLOGICAL MAKER |
|---|---|
| Original language | Chinese (Traditional) |
| Patent number | I408370 |
| IPC | G01N 33/574(2006.01); G01N 33/68(2006.01) |
| State | Published - 11 09 2013 |
Bibliographical note
公開公告號: I408370Announcement ID: I408370
